Related Experiment Videos
[Optimal use of the clinical microbiology laboratory by the clinician]
Therapeutische Umschau. Revue Therapeutique
|September 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The role of Aeromonas in diarrhea: a review.
Infection·2007
Rothia dentocariosa: taxonomy and differential diagnosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004
In vitro activities of BAL9141, a novel broad-spectrum pyrrolidinone cephalosporin, against gram-negative nonfermenters.
Antimicrobial agents and chemotherapy·2002
Antimicrobial therapy of infections with aerobic Gram-positive rods.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2001
[Drug Discovery - A surge in innovation driven by technology and artificial intelligence].
Therapeutische Umschau. Revue therapeutique·2026
[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].
Therapeutische Umschau. Revue therapeutique·2026
[Melanoma - an overview of the disease and its treatment].
Therapeutische Umschau. Revue therapeutique·2026
[Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].
Therapeutische Umschau. Revue therapeutique·2026
[Immune-related adverse events of immune checkpoint inhibitors].
Therapeutische Umschau. Revue therapeutique·2026
[Innovative drug development: ethical and regulatory challenges].
Therapeutische Umschau. Revue therapeutique·2026
Duration of same-species antimicrobial non-susceptibility persistence in urinary gram-negative bacilli: a 12-year within-patient cohort study.
Frontiers in cellular and infection microbiology·2026
Yeokwisan Attenuates Reflux-Induced Esophageal Injury and Suppresses Macrophage Inflammatory Responses Associated with MAPK/PI3K-Akt and NF-κB/COX-2 Signaling.
Pharmaceuticals (Basel, Switzerland)·2026